CBE Seminar: Pushing the Boundaries of Science Through Open Innovation
Open Innovation, Emerging Innovation Unit, Discovery Sciences
Non-UCI people- please use this registration link: https://forms.gle/4pyKsCuinkWuxFRx6
Abstract: AstraZeneca is a science‐led, patient focused biopharmaceutical company. At AstraZeneca, the focus is on enhanced innovation and the delivery of life‐changing medicines that contribute value to patients and society through four main areas: oncology, cardiovascular renal and metabolism (CVRM), respiratory and immunology, and rare disease. As the company looks into growth acceleration, collaboration is essential to deliver the defined strategies and leverage innovation. Through the Open Innovation program at AstraZeneca, compounds, tools, technologies and expertise are shared with the scientific community to develop new indications and advance drug delivery. Different programs are offered including CoSolve to share challenges faced within different therapeutic areas to find innovative and translatable solutions to address these challenges. The teams at AstraZeneca are looking for collaborators to work together on novel ideas to deliver new therapies and provide innovative solutions to real research challenges.
Bio: Saghar Nourian is originally from Tehran, Iran. She received her bachelor's and master's degrees in chemistry from Sharif University of Technology. In 2017, she completed her doctorate in chemistry at Johns Hopkins University. Prior to graduation, she was accepted into an R&D internship program that provided an opportunity to work with the analytical development team at MedImmune (acquired by AstraZeneca). She then joined the National Cancer Institute/National Institute of Health for her postdoctoral studies. Nourian started as a scientist 1 at MedImmune then became a senior scientist at AstraZeneca to work with the oncology and then emerging innovation teams.
Host: Assistant Professor Herdeline Ardoña